1,438
Views
17
CrossRef citations to date
0
Altmetric
Research Article

Synthesis, cyclooxygenase inhibition and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing methanesulphonyl pharmacophore

, , &
Pages 1545-1555 | Received 01 Nov 2015, Accepted 09 Feb 2016, Published online: 12 Apr 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Josiane V. Cruz, Silvana Giuliatti, Levy B. Alves, Raí C. Silva, Elenilze F. B. Ferreira, Njogu M. Kimani, Carlos H. T. P. Silva, João S. N. de Souza, José M. Espejo-Román & Cleydson B. R. Santos. (2022) Identification of novel potential cyclooxygenase-2 inhibitors using ligand- and structure-based virtual screening approaches. Journal of Biomolecular Structure and Dynamics 40:12, pages 5386-5408.
Read now
Tarek S. Ibrahim, Amr H. Moustafa, Ahmad J. Almalki, Rasha M. Allam, Abdulhamid Althagafi, Shadab Md & Mamdouh F. A. Mohamed. (2021) Novel chalcone/aryl carboximidamide hybrids as potent anti-inflammatory via inhibition of prostaglandin E2 and inducible NO synthase activities: design, synthesis, molecular docking studies and ADMET prediction. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1067-1078.
Read now
Halise Inci Gul, Cem Yamali, Fatma Yesilyurt, Hiroshi Sakagami, Kaan Kucukoglu, Ilhami Gulcin, Mustafa Gul & Claudiu T. Supuran. (2017) Microwave-assisted synthesis and bioevaluation of new sulfonamides. Journal of Enzyme Inhibition and Medicinal Chemistry 32:1, pages 369-374.
Read now

Articles from other publishers (14)

Mookkandi Palsamy Kesavan, Lokesh Ravi, Chandrasekar Balachandran, T. Daniel Thangadurai, Shin Aoki, Thomas J. Webster & Jegathalaprathaban Rajesh. (2023) Promising anticancer activity with high selectivity of DNA/plasma protein targeting new phthalazin-1(2H)-one heterocyclic scaffolds. Journal of Molecular Structure 1274, pages 134423.
Crossref
Mehlika AltintopDilekDilek, Halide TemelEdipEdip & Ahmet Özdemir. (2023) Microwave-assisted synthesis of a series of 4,5-dihydro-1H-pyrazoles endowed with selective COX-1 inhibitory potency. Journal of the Serbian Chemical Society 88:4, pages 355-365.
Crossref
Zabiulla, Fares Hezam Al-Ostoot, Hussien Ahmed Khamees, Nagendra Prasad MN, Farhan Zameer & Shaukath Ara Khanum. (2022) In-silico docking, synthesis, structure analysis, DFT calculations, energy frameworks, and pharmacological intervention of [1,3,4]-thiadiazoles analogous as XO inhibitor and on multiple molecular inflammatory targets COX and LOX. Journal of Molecular Structure 1270, pages 133963.
Crossref
Mehwash Zia, Shahid Hameed, Humaira Nadeem, Aamir Ali Kharl, Necmi Dege, Rehan Zafar Paracha, Iqra Arshad & Muhammad Moazzam Naseer. (2022) Synthesis, structure and acetylcholinesterase inhibition activity of new diarylpyrazoles. Bioorganic Chemistry 121, pages 105658.
Crossref
Noha H. Amin, Mohammed I.A. Hamed, Maha M. Abdel-Fattah, Ahmed H.A. Abusabaa & Mohammed T. El-Saadi. (2021) Design, synthesis and mechanistic study of novel diarylpyrazole derivatives as anti-inflammatory agents with reduced cardiovascular side effects. Bioorganic Chemistry 116, pages 105394.
Crossref
Begüm EVRANOS AKSÖZ. (2021) MOLECULAR DOCKING STUDIES ON SOME 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVES AS CYCLOOXYGENASE INHIBITORS. Ankara Universitesi Eczacilik Fakultesi Dergisi.
Crossref
Larissa Córdova Turones, Aline Nazareth Martins, Lorrane Kelle da Silva Moreira, James Oluwagbamigbe Fajemiroye & Elson Alves Costa. (2020) Development of pyrazole derivatives in the management of inflammation. Fundamental & Clinical Pharmacology 35:2, pages 217-234.
Crossref
Betül Kaya Çavuşoğlu, Begüm N. Sağlık, Ulviye Acar Çevik, Derya Osmaniye, Serkan Levent, Yusuf Özkay & Zafer A. Kaplancıklı. (2020) Design, synthesis, biological evaluation, and docking studies of some novel chalcones as selective COX‐2 inhibitors. Archiv der Pharmazie 354:3, pages 2000273.
Crossref
Siva S Panda, Adel S Girgis, Hitesh H Honkanadavar, Riham F George & Aladdin M Srour. (2020) Synthesis of new ibuprofen hybrid conjugates as potential anti-inflammatory and analgesic agents. Future Medicinal Chemistry 12:15, pages 1369-1386.
Crossref
Vesna Milovanović, Zorica D. Petrović, Slađana Novaković, Goran A. Bogdanović, Dušica Simijonović & Vladimir P. Petrović. (2019) Structural characterization of benzoyl-1H-pyrazole derivatives obtained in lemon juice medium: Experimental and theoretical approach. Journal of Molecular Structure 1195, pages 85-94.
Crossref
Khaled RA Abdellatif, Mohammed T El-Saadi, Shaimaa G Elzayat & Noha H Amin. (2019) New substituted pyrazole derivatives targeting COXs as potential safe anti-inflammatory agents. Future Medicinal Chemistry 11:15, pages 1871-1882.
Crossref
Cüneyt Türkeş, Mustafa Arslan, Yeliz Demir, Liridon Çoçaj, Arleta Rifati Nixha & Şükrü Beydemir. (2019) Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorganic Chemistry 89, pages 103004.
Crossref
Dušica Simijonović, Zorica D. Petrović, Vesna M. Milovanović, Vladimir P. Petrović & Goran A. Bogdanović. (2018) A new efficient domino approach for the synthesis of pyrazolyl-phthalazine-diones. Antiradical activity of novel phenolic products. RSC Advances 8:30, pages 16663-16673.
Crossref
Khosrow Kashfi & Mahnoush Esmaili. 2017. Nitric Oxide as a Chemosensitizing Agent. Nitric Oxide as a Chemosensitizing Agent 105 142 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.